Perrigo PE Ratio 2010-2024 | PRGO
Current and historical p/e ratio for Perrigo (PRGO) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Perrigo PE ratio as of May 10, 2024 is 12.69.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Perrigo PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-05-10 | 30.71 | 0.00 | |
2024-03-31 | 32.19 | $-0.08 | 0.00 |
2023-12-31 | 31.88 | $-0.10 | 0.00 |
2023-09-30 | 31.37 | $0.05 | 627.49 |
2023-06-30 | 33.08 | $-0.42 | 0.00 |
2023-03-31 | 34.66 | $-0.96 | 0.00 |
2022-12-31 | 32.69 | $-0.96 | 0.00 |
2022-09-30 | 33.92 | $-0.63 | 0.00 |
2022-06-30 | 38.32 | $-0.70 | 0.00 |
2022-03-31 | 36.06 | $-0.65 | 0.00 |
2021-12-31 | 36.24 | $-1.92 | 0.00 |
2021-09-30 | 43.80 | $-3.29 | 0.00 |
2021-06-30 | 42.19 | $-2.41 | 0.00 |
2020-12-31 | 40.70 | $-1.21 | 0.00 |
2020-09-30 | 41.59 | $-0.06 | 0.00 |
2020-06-30 | 49.86 | $1.35 | 36.93 |
2020-03-31 | 43.20 | $1.58 | 27.34 |
2019-12-31 | 46.21 | $0.88 | 52.51 |
2021-03-31 | 37.05 | $1.49 | 24.87 |
2019-09-30 | 49.79 | $1.81 | 27.51 |
2019-06-30 | 42.23 | $0.65 | 64.97 |
2019-03-31 | 42.50 | $0.84 | 50.60 |
2018-12-31 | 34.07 | $0.94 | 36.24 |
2018-09-30 | 62.24 | $0.86 | 72.38 |
2018-06-30 | 63.94 | $1.66 | 38.52 |
2018-03-31 | 72.90 | $0.91 | 80.10 |
2017-12-31 | 76.05 | $0.84 | 90.54 |
2017-09-30 | 73.73 | $-9.16 | 0.00 |
2017-06-30 | 65.64 | $-18.23 | 0.00 |
2017-03-31 | 57.58 | $-16.39 | 0.00 |
2016-12-31 | 72.03 | $-19.23 | 0.00 |
2016-09-30 | 79.77 | $-10.49 | 0.00 |
2016-06-30 | 78.21 | $-0.96 | 0.00 |
2016-03-31 | 110.18 | $-2.98 | 0.00 |
2015-12-31 | 124.48 | $-0.13 | 0.00 |
2015-09-30 | 135.18 | $1.33 | 101.64 |
2015-03-31 | 142.11 | $0.56 | 253.77 |
2014-12-31 | 143.38 | $1.59 | 90.18 |
2014-09-30 | 128.74 | $0.21 | 613.03 |
2014-06-30 | 124.85 | $0.67 | 186.34 |
2014-03-31 | 132.37 | $0.67 | 197.57 |
2013-12-31 | 131.26 | $1.49 | 88.09 |
2013-09-30 | 105.47 | $3.48 | 30.31 |
2013-06-30 | 103.36 | $3.42 | 30.22 |
2013-03-31 | 101.35 | $3.42 | 29.63 |
2012-12-31 | 88.72 | $3.47 | 25.57 |
2012-09-30 | 98.99 | $3.41 | 29.03 |
2012-06-30 | 100.42 | $3.04 | 33.03 |
2012-03-31 | 87.90 | $3.04 | 28.91 |
2011-12-31 | 82.72 | $2.76 | 29.97 |
2011-09-30 | 82.49 | $2.67 | 30.89 |
2011-06-30 | 74.58 | $2.72 | 27.42 |
2011-03-31 | 67.44 | $2.72 | 24.79 |
2010-12-31 | 53.66 | $2.43 | 22.08 |
2010-09-30 | 54.35 | $1.84 | 29.54 |
2010-06-30 | 49.94 | $1.59 | 31.41 |
2010-03-31 | 49.59 | $2.25 | 22.04 |
2015-06-30 | 158.77 | $1.59 | 99.85 |
2009-12-31 | 33.59 | $1.70 | 19.76 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $4.186B | $4.656B |
Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $182.209B | 23.86 |
Stryker (SYK) | United States | $125.934B | 30.16 |
Medtronic (MDT) | Ireland | $109.997B | 15.57 |
Boston Scientific (BSX) | United States | $108.110B | 34.44 |
EssilorLuxottica (ESLOY) | France | $100.536B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $43.244B | 0.00 |
Haleon (HLN) | United Kingdom | $37.625B | 27.47 |
ResMed (RMD) | United States | $31.412B | 29.49 |
Terumo (TRUMY) | Japan | $25.118B | 35.47 |
Koninklijke Philips (PHG) | Netherlands | $24.962B | 19.34 |
Zimmer Biomet Holdings (ZBH) | United States | $24.957B | 15.94 |
Baxter (BAX) | United States | $18.187B | 12.93 |
Insulet (PODD) | United States | $11.617B | 51.52 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.025B | 0.00 |
Demant (WILYY) | Denmark | $10.234B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $8.042B | 26.31 |
BellRing Brands (BRBR) | United States | $7.836B | 36.71 |
Lantheus Holdings (LNTH) | United States | $5.269B | 13.13 |
Haemonetics (HAE) | United States | $4.868B | 24.08 |
GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
Prestige Consumer Healthcare (PBH) | United States | $3.495B | 16.52 |
Envista Holdings (NVST) | United States | $3.186B | 13.15 |
QuidelOrtho (QDEL) | United States | $2.854B | 15.84 |
Green Thumb Industries (GTBIF) | United States | $2.719B | 53.86 |
Neogen (NEOG) | United States | $2.671B | 25.69 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.630B | 0.00 |
ICU Medical (ICUI) | United States | $2.610B | 23.03 |
TG Therapeutics (TGTX) | United States | $2.569B | 72.26 |
Agios Pharmaceuticals (AGIO) | United States | $1.874B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.717B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.709B | 50.09 |
InMode (INMD) | Israel | $1.520B | 8.08 |
Warby Parker (WRBY) | United States | $1.466B | 0.00 |
Owens & Minor (OMI) | United States | $1.425B | 12.42 |
AdaptHealth (AHCO) | United States | $1.285B | 9.57 |
National Vision Holdings (EYE) | United States | $1.160B | 36.90 |
AtriCure (ATRC) | United States | $1.061B | 0.00 |
Canopy Growth (CGC) | Canada | $0.917B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.885B | 0.00 |
Evolus (EOLS) | United States | $0.798B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.726B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.711B | 15.13 |
Quanterix (QTRX) | United States | $0.638B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.628B | 14.77 |
PetIQ (PETQ) | United States | $0.543B | 17.73 |
Jin Medical (ZJYL) | China | $0.536B | 0.00 |
Valneva SE (VALN) | France | $0.517B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.487B | 0.00 |
Surmodics (SRDX) | United States | $0.459B | 28.71 |
Biote (BTMD) | United States | $0.456B | 8.74 |
ZimVie (ZIMV) | United States | $0.454B | 38.72 |
OraSure Technologies (OSUR) | United States | $0.359B | 11.57 |
Aurora Cannabis (ACB) | Canada | $0.352B | 0.00 |
Zynex (ZYXI) | United States | $0.333B | 45.61 |
Cerus (CERS) | United States | $0.320B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.277B | 27.48 |
Sanara MedTech (SMTI) | United States | $0.271B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.263B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.247B | 15.28 |
MacroGenics (MGNX) | United States | $0.207B | 0.00 |
Omeros (OMER) | United States | $0.203B | 0.00 |
Veru (VERU) | United States | $0.195B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.182B | 0.00 |
High Tide (HITI) | Canada | $0.180B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.178B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.172B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.167B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.146B | 70.00 |
InterCure (INCR) | Israel | $0.145B | 24.54 |
FitLife Brands (FTLF) | United States | $0.138B | 22.22 |
Jushi Holdings (JUSHF) | United States | $0.136B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.110B | 0.00 |
Fonar (FONR) | United States | $0.107B | 9.17 |
MariMed (MRMD) | United States | $0.098B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.094B | 0.00 |
Brainsway (BWAY) | Israel | $0.089B | 0.00 |
Chimerix (CMRX) | United States | $0.087B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.064B | 0.00 |
Safety Shot (SHOT) | United States | $0.059B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.85 |
Apyx Medical (APYX) | United States | $0.052B | 0.00 |
Cytosorbents (CTSO) | United States | $0.049B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.048B | 0.00 |
ImmuCell (ICCC) | United States | $0.043B | 0.00 |
Bright Green (BGXX) | United States | $0.040B | 0.00 |
United-Guardian (UG) | United States | $0.039B | 14.08 |
Modular Medical (MODD) | United States | $0.038B | 0.00 |
Exagen (XGN) | United States | $0.027B | 0.00 |
Nephros (NEPH) | United States | $0.022B | 0.00 |
Agape ATP (ATPC) | $0.019B | 0.00 | |
Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
Flora Growth (FLGC) | United States | $0.018B | 0.00 |
GlucoTrack (GCTK) | United States | $0.015B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.014B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.011B | 74.77 |
IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.003B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |